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a b s t r a c t
Aims:Abnormal sympathetic innervation triggers ventricular ﬁbrillation (VF).We examined the circadian
variation of autonomic nervous system and its relevance to risk stratiﬁcation of VF in patients with
Brugada syndrome (Brs).
Methods: We enrolled 12 male Brs patients with documented VF (Brs-S; mean age, 42±4 years), 17
without documented VF (Brs-N; mean age 48±4 years), and 16 age- and gender-matched controls. The
clinical data, 12-lead electrocardiography (ECG), signal-averaged ECG, electrophysiological study (EPS),
and heart rate variability from 24h Holter ECG were compared between the groups.
Results: The low frequency components (LF) in Brs-S and Brs-N and high frequency components (HF)
in Brs-S patients were signiﬁcantly lower than in the controls (409.8±128.6ms2, 329.5±108ms2 vs.
945.3±111.3ms2; 135.1±73.8ms2 vs. 391.8±63.9ms2, respectively). The circadian variation of the LF
2andLF/HFdecreased in theBrspatients, the standarddeviation (SD)of LF/HF (<2.5) andSDof LF (<400ms )
had sufﬁciently high sensitivity (96.6%) and speciﬁcity (92.9%) for the diagnosis of Brs. Most of the Brs-S
patients (83.3%) were located under the line formed by the SD/mean of HF=SD/mean of LF in the scatter
plots.
Conclusion: Lack of the circadian variation of autonomic function occurs in Brs, and this may contribute
to the pathogenesis of VF.
© 2013 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.ntroduction
Many reports have documented the role of abnormal sym-
athetic innervation as a trigger of ventricular ﬁbrillation (VF)
1–6]. Brugada syndrome (Brs) is one of the major causes of
F and a signiﬁcant circadian peak from midnight to early
orning in VF has been reported in patients with Brs [7]. Presy-
aptic sympathetic abnormalities of the heart in patients with
rs have been documented using positron emission tomography
nd [123I]m-iodobenzylguanidine-single-photon emission com-
uted tomography [8,9]. A predominance of a vagal tone has
lso been reported in patients with Brs using the head-up tilt
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ttp://dx.doi.org/10.1016/j.jjcc.2013.12.001test [10,11]. With regard to the heart rate variability (HRV),
some studies have reported decreased HRV in patients with
Brs. However, most of those reports dealt with asymptomatic
patients and there are only a few reports with various results
discussing differences in the HRV between symptomatic and
asymptomatic Brs [10,12,13]. There are many reports discussing
the risk stratiﬁcation of VF in Brs [14–23]. However, these param-
eters were inadequate and the risk stratiﬁcation of VF in Brs
remains controversial. The relationship between the autonomic
nervous system and VF in Brs patients remains to be fully eluci-
dated.
We investigated the circadian variations in autonomic nervous
system using the HRV from 24-hour Holter electrocardiography
(24-h ECG) in patients with Brs. Furthermore, we investigated
whether an abnormal autonomicnervous systemwas related to the
pathogenesis of ahigher incidenceof lethal ventricular arrhythmias
associated with Brs.

























































ean age, 42±4 years), 17 without documented VF (Brs-N group;
ean age, 48±4 years), and 16 age- and gender-matched controls
mean age, 43±4 years) without structural heart disease, arrhyth-
ias, and diseases affecting the autonomic nervous system. Among
he enrolled patients, seven had a family history of sudden cardiac
eath. Noninvasive examinations revealed normal cardiac struc-
ure and function in all patients. Brs was deﬁnitively diagnosed
hen a type 1 ST-segment elevation was observed in >1 right pre-
ordial lead (V1 to V3) in the presence or absence of a sodium
hannel-blocking agent and in conjunction with one of the crite-
ia of the Brs consensus conference [11]. A baseline examination
evealed a spontaneous type 1 Brugada ECG pattern in 27 patients
nd type2BrugadaECGpatternatbaseline in2patientswhounder-
ent a pharmacological challenge test with a pilsicainide injection
1mg/kg body weight/10min), which subsequently converted to a
ype 1 ECG pattern in more than one right precordial lead.
We retrospectively compared the following parameters in the
rs-S and Brs-N groups: (1) a history of syncope and family history
f sudden cardiac death; (2) occurrence rate of paroxysmal atrial
brillation; (3) 12-lead ECG parameters and type of Brugada ECG;
4) signal-averaged ECG ﬁndings; (5) electrophysiological study
EPS) parameters and induction of VF/ventricular tachycardia (VT)
ith burst pacing and triple paired extrastimuli from the right ven-
ricular apex and right ventricular outﬂow tract; and (6) genetic
nalysis for the SCN5A gene which encodes for the -subunit of
he human cardiac sodium channel (hNav1.5).
We thoroughly investigated the HRV and also compared the
ower and ﬂuctuation in the time and frequency domains of the
RV in the Brs-S, Brs-N, and controls.
The study was approved by Ethical Review Committee of our
nstitution.
welve-lead ECG ﬁndings
The 12-lead ECG was recorded at a speed of 25mm/s and an
mpliﬁcation of 1 cm/mV. We measured the RR, PQ, QRS, and cor-
ected QT (QTc) intervals in lead V6 and the J-point amplitude in
eads V1 and V2 (STJ). We classiﬁed the Brugada ECG patterns into
ypes 1–3, according to the criteria of the Brs consensus conference
11]. Because the ST conﬁgurations in the right precordial leads
re known to show a day-to-day variation, more than ﬁve ECGs
ere recorded on different days for each patient. When a sponta-
eous type 1 Brugada ECG pattern was recorded at least once from
patient with Brs, that patient was identiﬁed as having a type 1
CG pattern.
ignal-averaged ECG ﬁndings
Late potentials were analyzed using an FP-705LP system
Fukuda Denshi, Tokyo, Japan). The ECG was recorded using Frank
, Y, andZ leadsduring sinus rhythm, and the signals from300beats
ere ampliﬁed, digitized, averaged, andﬁlteredwithbackward and
orward ﬁlters at a high band-pass frequency of 40Hz. The ﬁltered
RS duration (f-QRS), root mean square voltage of the terminal
-QRS segment (RMS 40), and duration of low-amplitude signals
40V in the terminal f-QRS segment (LAS 40) were calculated.
ate potentials were identiﬁed as being present when two of the
ollowing criteria were satisﬁed: f-QRS >114ms, RMS 40 <20V, or
AS 40 >38ms [24].diology 64 (2014) 133–138
Heart rate variability
Each subject underwent 24-h ECG monitoring, and we analyzed
the total heart beats, minimum, maximum, and mean heart rate
during 24h. We obtained heart beats without premature beats
and other arrhythmias, and used them for the analysis of the HRV
(SCM-6600TM, Fukuda Denshi or MARSTM, Ambulatory ECG system
ver.8, GE Medical Systems, Milwaukee, WI, USA). We performed
time domain and frequency domain analyses (Fast Fourier trans-
formation)with the data. The time domain indiceswere as follows:
the standard deviation (SD) of normal sinus RR intervals (SDNN),
SD of the average normal sinus RR intervals every 5min (SDANN),
average SD of normal sinus RR intervals every 5min (ASDNN), and
root mean square of successive normal sinus RR interval differ-
ence (rMSSD). The frequency domain indices were as follows: very
low frequency component (VLF): 0.003–0.04Hz; low frequency
component (LF): 0.04–0.15Hz that reﬂects the modulation of the
sympathetic and parasympathetic tone by baroreﬂex activity; high
frequency component (HF): 0.15–0.4Hz that reﬂects the modula-
tion of the vagal tone; and the ratio of the LF to HF [25]. Themethod
of normalizing is [Normalized LF] = (LF− [mean of LF])/[SD of LF].
The data were normalized to have mean=0 and variance =1. LF*
is the moving average of the LF. Here, the LF* at time t is given as
the average of the LFs at time t, t−1hour and t+1hour. None of
the subjects took any antiarrhythmic agent and we conﬁrmed all
of the subjects with implantable cardioverter deﬁbrillators were
in regular sinus rhythm without pacing during recording the 24-h
ECG monitoring.
EPS and VT/VF induction
After informedconsentwasobtained fromthepatients and their
families, an EPS was performed in all patients. Three 5 French-
quadripolar electrode catheterswith 5-mminter-electrode spacing
were positioned in the high right atrium, bundle of His, and right
ventricular apex. Programmed ventricular stimulation was per-
formed in all patients with burst pacing [up to 230 beats per min
(bpm)] and up to triple extrastimuli at two different drive cycle
lengths (400 and 600ms) from the right ventricular apex and right
ventricular outﬂow tract. The shortest coupling interval of prema-
ture beats was limited to 200ms.
Sequence analysis of SCN5A using genomic DNA
Peripheral blood samples were obtained from all patients, and
the genomic DNA was extracted from leukocytes according to the
standard protocol using a QIAamp DNA Blood Maxi Kit (QIAGEN,
Hilden, Germany). All SCN5A exons and their splice sites were
ampliﬁed by a polymerase chain reaction from 2.5ng of genomic
DNA with GO Taq DNA polymerase (Promega, Madison, WI, USA).
The samples were resequenced using the 64 sense and antisense
primers (approximately 300bp each) of SCN5A with an ABI PRISM
310 Genetic Analyzer (Applied Biosystems, Foster City, CA, USA).
Statistical analyses
Statistical analysis was performed using commercially avail-
able software (JMP 8.0.2 Software, SAS Institute Inc., Cary, NC,
USA). Values are presented as the mean± standard error (SE). A
Mann–Whitney U test was used to compare the continuous vari-
ables between two groups. The continuous variables among the
three different groups were analyzed using Kruskal–Wallis and
Steel–Dwas tests. The 2 test and Fisher’s exact test were used to
evaluate the differences in the categorical variables between the
subgroups. We used a repeated measures of ANOVA with a Fried-
man’s Test to evaluate the HF, LF, and LF/HF every hour in the three










































Comparison of the clinical, electrocardiographic and electrophysiologic ﬁndings
between Brs-S group and Brs-N group.
Brs-S group (N=12) Brs-N group (N=17) p value
Clinical data
PAF 3 (25%)* 2 (12%) 0.0407
Syncope 3 (25%) 3 (18%) 0.6302
Family History of SCED 3 (25%) 4 (24%) 0.9274
SCN5A 2 (17%) 0 (0%) 0.1249
Twelve leads ECG ﬁndings
RR (ms) 967±41 895±33 0.1855
PQ (ms) 185±11 169±9 0.2538
QRS (ms) 156±26 149±21 0.8281
QTc (ms) 414±9 424±7 0.4105
V1STJ(mV) 4.0±1.4 2.9±1.3 0.5600
V2STJ(mV) 4.3±1.2 2.9±1.1 0.4194
Spontaneous type 1 ECG 10 (83%) 13 (76%) 0.6532
Signal averaged ECG ﬁndings
Positive LPs 8 (67%) 13 (76%) 0.5077
fQRSd (ms) 173.2±9.7 164.4±7.7 0.4831
RMS 40 (V) 48.2±2.4 13.3±1.9 0.8741
LAS 40 (ms) 48.2±5.2 48.4±4.1 0.9792
EPS ﬁndings
AH (ms) 106.3±6.5 99.9±4.8 0.4408
HV (ms) 47.6±3.4 50.7±2.5 0.4649
AVN ERP (ms) 383.3±30.3 359.2±21.8 0.5307
SNRT (ms) 1299±255 1385±187 0.7894
VF induction 10 (83%) 9 (53%) 0.0931
Data were mean± SE. Brs-S group, patients of Brugada syndrome with documented
ventricular ﬁbrillation; Brs-N group, patients of Brugada syndrome without doc-
umented ventricular ﬁbrillation; PAF, paroxysmal atrial ﬁbrillation; SCD, sudden
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roups. A value of p<0.05 was considered statistically signiﬁcant.
oreover, a cluster analysis was used to generate a dendrogram
Ward’s minimum variance algorithm) grouping a set of objects in
similar wave of the circadian variation [26].
esults
The clinical characteristics and electrocardiographic and elec-
rophysiological ﬁndings in the Brs-S and Brs-N groups are shown
n Table 1. A previous history of paroxysmal atrial ﬁbrillation was
ore frequent in the Brs-S group than in the Brs-N group. The pro-
ortion of patients with syncope history, patients with a family
istory of sudden cardiac death, ECG parameters, rate of positive
ate potentials, EPS parameters including the induction rate of VF,
nd a positive mutation rate of SCN5A were similar between the
wo groups. Table 2 shows a comparison of the 24-h ECG ﬁndings
nd results of the time and frequency domain analyses in the Brs-
, Brs-N, and controls. The total heart beats and mean heart rate
uring 24h were signiﬁcantly lower in the Brs-S group than in the
ontrols (90122±4908 beats vs. 106328±4070 beats, p=0.0281
nd 68±3bpm vs. 77±2bpm, p=0.0303, respectively). The other
arameters of the time domain analysis were similar among the
hree groups. With regard to the frequency domain analysis, the
F power was signiﬁcantly lower in the Brs-S and Brs-N groups
han that in the controls (409.8±128.6ms2 and 329.5±108ms2
s. 945.3±111.3ms2, p=0.0006, respectively). In addition, the HF
ower was signiﬁcantly lower in the Brs-S group than in the con-
rols (135.1±73.8ms2 vs. 391.8±63.9ms2, p=0.0112). Fig. 1(a)
ontains the scatter plots of the SD of LF vs. SD of LF/HF for the
hree groups. Most of the patients in Brs had a smaller SD of LF and
F/HF than those in the controls. We set the SD cut-off values for
he LF/HF at <2.5 and for the LF at <400ms2. Those cut-off values
ad sufﬁciently high sensitivity (96.6%) and speciﬁcity (92.9%) for
he diagnosis of Brs. Fig. 1(b) also shows the scatter plots of the
D/mean of the HF and that of the LF, where most of the patients
n the Brs-S group (83.3%) were located under the line indicated
y the SD/mean of HF=SD/mean of LF. We plotted the HF, LF, and
F/HF every hour (Fig. 2) and found that the LF and LF/HF circadian
ariation decreased more in the Brs-S and Brs-N groups than in the
ontrols.In addition, in the dendrogram obtained by a cluster analysis of
he circadian variation of normalized LF*, we found a large group
hat consisted of only patients with symptomatic Brs. In the Brs-
patients, the nocturnal LF changes decreased, particularly from
able 2
omparison of the 24h-Holter ECG ﬁndings including results of time domain and frequen
Brs-S group (N=12) Br
Total hearts beats 90122 ± 4908* 9
Maximum heart rate (bpm) 127 ± 6
Minimum heart rate (bpm) 47 ± 2
Mean heart rate (bpm) 68 ± 3
Mean RR interval (ms) 891 ± 32
SDNN (ms) 131.7 ± 12.7
SDANN (ms) 114.5 ± 12.2
ASDNN (ms) 57.5 ± 5.7
rMSSD (ms2) 28.8 ± 3.2
VLF (ms2) 1463.9 ± 405.5* 1
LF (ms2) 409.8 ± 128.6*
HF (ms2) 135.1 ± 73.8*
LF/HF 3.25 ± 0.53
ataweremean± SE. Brs-S group, patients of Brugada syndromewithdocumentedventric
entricular ﬁbrillation; SDNN, standard deviation of normal sinus RR intervals; SDANN, s
f standard deviation of normal sinus RR intervals every 5min; rMSSD, root mean square
F, high frequency; LF/HF, ratio of LF to HF.
* p<0.05 vs. controls.EPS, electrophysiologic study; ERP, effective refractory period; SNRT, sinus node
recovery time; VF, ventricular ﬁbrillation.
* p<0.05 Brs-S group vs. Brs-N group.
evening to midnight, and drastically rose at midnight compared
with control patients (Fig. 3).
Discussion
The major ﬁnding of this study was that the HRV decreased
in patients with Brs over 24h, and lack of the circadian variation
of the HRV may contribute to the pathogenesis of life-threatening
arrhythmias in Brs.We could distinguish Brs using the cut-off value
of the SD of LF and SD of LF/HF with a high sensitivity and speci-
ﬁcity. Inaddition,wecoulddistinguish thepatientswithBrs-Susing
scatter plots of the SD/mean of the HF and LF, to some extent. Fur-
thermore, we found a large group consisting of only patients with
cy domain analysis among Brs-S group, Brs-N group and controls.
s-N group (N=12) Controls (N=16) p value
3888 ± 3948 106328 ± 4070 0.0281
118 ± 4 131 ± 5 0.1088
50 ± 2 52 ± 2 0.2837
70 ± 2 77 ± 2 0.0303
865 ± 27 813 ± 29 0.1829
123.4 ± 10.7 154.9 ± 11.4 0.1312
109.4 ± 10.2 140.4 ± 10.9 0.1052
49.5 ± 4.8 59.7 ± 5.1 0.3197
26.1 ± 2.7 28.2 ± 3.2 0.7903
044.9 ± 340.7* 3215.2 ± 351.1 0.0002
329.5 ± 108* 945.3 ± 111.3 0.0006
143.1 ± 62* 391.8 ± 63.9 0.0112
2.62 ± 0.45 3.76 ± 0.46 0.2156
ular ﬁbrillation; Brs-Ngroup, patientswithBrugada syndromewithout documented
tandard deviation of average of normal RR intervals every 5min; ASDNN, average
differences of successive RR intervals; VLF, very low frequency; LF, low frequency;
136 T. Tokuyama et al. / Journal of Cardiology 64 (2014) 133–138
Fig. 1. (a) The scatter plots of the standard deviation (SD) of LF versus the SD of LF/HF for each subject in the three groups. Most of the patients with Brugada syndrome fall
w ts of t
o /mean








cithin a range of the SD of LF/HF <2.5 and the SD of LF <400ms2. (b) The scatter plo
f the patients in Brs-S group (83.3%) were located under the line indicated by [SD
brillation; BRS-N, Brugada syndrome without documented ventricular ﬁbrillation
rs-S whose circadian variation of the normalized LF differed from
hat of patients with Brs-N and the controls.
Many studies have documented the role of abnormal sym-
athetic innervation as a trigger of VF [1–6]. Most ventricular
rrhythmic events are nocturnal, particularly in patients with Brs
7], suggesting the inﬂuence of the autonomic nervous system.
ig. 2. The LF (a), HF (b) and LF/HF (c) every hour were plotted in the groups. The LF and
ontrols group. Brs-S, Brugada syndrome with documented ventricular ﬁbrillation; BRS-N
omponents; HF, high frequency components.he SD/mean of HF and the SD/mean of LF for each subject in the three groups. Most
of HF] = [SD/mean of LF]. Brs-S, Brugada syndrome with documented ventricular
w frequency components; HF, high frequency components.
Previous studies reported presynaptic sympathetic abnormalities
of the heart in patients with Brs using positron emission tomog-
raphy and [123I]m-iodobenzylguanidine-single-photon emission
computed tomography [8,9]. Adopting a different technique for
testing the autonomic nervous activity, Kostopoulou et al. reported
the predominance of the vagal tone in Brs using the head-up tilt
LF/HF circadian variation decreased more in the Brs-S and Brs-N groups than in the
, Brugada syndrome without documented ventricular ﬁbrillation; LF, low frequency
T. Tokuyama et al. / Journal of Cardiology 64 (2014) 133–138 137



































bidnight and drastically rose at midnight. The LF* is the moving average of the LF. H
rs-S, Brugada syndrome with documented ventricular ﬁbrillation; LF, low frequen
est, but a positive test result did not have any prognostic value
or life-threatening arrhythmias. With regard to the HRV, the same
eport revealed that theHRVwas similar between the patientswith
rs and the controls [9]. Pierre et al. reported that patients with a
rugada-like ECG had lower HRV and QT/RR slopes than control
ubjects during the night [27]. Krittayaphong et al. reported that
atients with asymptomatic Brs had a lower HRV or vagal tone at
ight than controls [10]. Most patients with Brs in previous reports
ere asymptomatic, and there have been no reports discussing the
ifference with regard to the HRV in patients with Brs with and
ithout VF. Despite serious efforts of many researchers, controver-
ies remain with regard to the risk stratiﬁcation of VF in patients
ith Brs [14–23] and whether abnormal autonomic nervous sys-
em activity is related to the higher incidence of lethal ventricular
rrhythmias in Brs.
In our study, there was no signiﬁcant difference in the presence
f a family history of sudden cardiac death, 12-lead ECG parame-
ers, rate of positive late potentials, EPS parameters, inducibility of
F, or rate of SCN5Amutations between the Brs-S and Brs-N groups.
n our report, a past history of atrial ﬁbrillation was more prevalent
n our subjects with Brs than in men of the same generation, and it
as signiﬁcantly higher in the Brs-S group than in the Brs-N group.
ecently, Rodríguez-Man˜ero et al. reported that atrial ﬁbrillation
ould be one of the ﬁrst clinical manifestations of latent Brs [28].
akagi et al. reported the clinical characteristics and risk stratiﬁ-
ation in patients with symptomatic Brs and a high incidence of a
revious history of atrial ﬁbrillation in patients with symptomatic
rs [23].
As for the investigation of the 24-h ECG, the total heart beats
nd mean heart rate from the 24-h ECG were signiﬁcantly lower
n the Brs-S and Brs-N groups than in the controls. Previous papers
eported the manifestation of sinus node dysfunction in patients
ith Brs with SCN5A mutations [29]. In our study, the sinus node
unction in the EPS and frequency of SCN5A mutations were similar
etween our Brs-S and Brs-N groups.he LF* at time t is given as the average of the LFs at time t, t−1hour and t+1hour.
ponents.
An HRV analysis showed that the LF and HF power were lower
in patients with Brs than in the controls. These results suggest that
the vagal activity in patients with Brs consistently decreased in
past reports [10,11]. Further investigation of the ﬂuctuation in the
HRV in our study revealed that the circadian variations in LF and
LF/HF over 24h were lower in patients with Brs than in the con-
trols. The differences in the HRV in Brs patients with and without
VF and similar investigation were already reported in a few papers
as various results. Hermida et al. reported that 5min averaged
NN intervals (SDANN) was an independent marker of arrhythmic
events in Brs patients, but frequency domain analysis of HRV were
similar between symptomatic and asymptomatic Brs patients [12].
Their symptomatic patients included patients with history of syn-
cope without VF history. Krittayaphong et al. reported that LF and
HF in night time were lower in Brs patients than those in asymp-
tomatic Brs ECG patients [10]. In the other reports, Nakazawa et al.
reported that during the night (00.00–05.00h), the HF was signiﬁ-
cantly higher and LF/HF was signiﬁcant lower in Brs with VF than
thosewithout [13].We could distinguish the patientswith Brswith
a high sensitivity and speciﬁcity using the SD of LF and SD of LF/HF
cut-off values. In addition, we could distinguish the patients with
Brs-S using the plots of the SD/mean of the HF and SD/mean LF
in scatter plots to some extent. To the best of our knowledge, this
was theﬁrst trial to quantitatively distinguish patientswith Brs and
stratify high-risk patients using circadian ﬂuctuations in the HRV.
The circadian variation of the LF and LF/HF in Brugada syn-
drome patients may represent deterioration in circadian variation
of sympathetic and parasympathetic nerve balance. We cannot
clearly explain the mechanism why circadian variation of the LF
and LF/HF was impaired in Brugada syndrome. Kies et al. pre-
sumed that autonomic innervation in Brugada syndrome describes
an enhanced presynaptic norepinephrine recycling with preserved
-adrenoceptor density [6]. But, in their reports, they did not
assess parasympathetic innervation. In another report, Taggart

















































[38 T. Tokuyama et al. / Journal
erve activity was related to the cardiac arrhythmia [30]. The
echanism of impaired circadian variation of autonomic activity
n patients with Brs remains to be solved.
In addition, in the dendrogram obtained from a cluster anal-
sis of the circadian variation of the normalized LF, we found a
arge group consisting of only patients with Brs-S. The patterns of
he circadian variation in all patients were heterogenic and it was
xtremely difﬁcult to draw an absolute line between the patients
ith symptomatic and asymptomatic Brs. However, in this large
roup consisting of only patients with Brs-S, an identical pattern
as indicated where the nocturnal changes in the LF decreased,
articularly from evening to midnight and drastically rose at mid-
ight.
In conclusion, there was a lack of the circadian variations in the
RV with Brs, and this autonomic nervous abnormality may con-
ribute to the pathogenesis of life-threatening arrhythmias in Brs
atients.
imitations
There were several limitations in the present study. We exam-
ned only a small number of patients in a single institution; thus,
he ﬁndings in our study need to be validated in a larger group
f patients. The HRV data greatly varies and differs with age. All
he subjects in our study were male and most were approximately
0 years old. Thus, our results may reﬂect only a limited cohort of
atients with Brs. The relationship between the HRV and Brs has
o be widely veriﬁed; however, to the best of our knowledge, this
s the ﬁrst report demonstrating ﬂuctuations in the HRV and lethal
rrhythmias in patients with Brs.
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